Risk Assessment of Chronic Cough From Indoor Pollutants

Abstract

Chronic cough is a prevalent and often distressing symptom encountered in clinical practice, with mounting evidence implicating indoor pollutants as significant etiological factors. This review synthesizes current scientific understanding of the association between indoor air quality and chronic cough, highlighting epidemiological trends, pathophysiological mechanisms, and risk stratification. Emphasis is placed on the clinical implications for healthcare professionals, including diagnostic strategies, management options, and the integration of recent guideline recommendations. The review aims to provide clinicians with a comprehensive and practical framework for risk assessment and management of chronic cough attributable to indoor pollutants.

Introduction

Chronic cough, defined as a cough persisting for more than eight weeks, is a common complaint in both primary and specialized care settings. While infectious and allergic etiologies are well recognized, environmental exposures, particularly to indoor pollutants, have gained increasing attention as key contributors to persistent cough. Indoor air pollution encompasses a complex mixture of particulate matter, volatile organic compounds (VOCs), biological agents, and combustion by-products, all of which may synergistically impact respiratory health. Understanding the interplay between these exposures and chronic cough is crucial for advancing patient care and informing public health interventions.

Epidemiology / Disease Burden

Recent epidemiological studies estimate the global prevalence of chronic cough ranges from 2% to 18% among adults, with higher rates observed in urbanized and industrialized regions. Indoor air pollution is recognized as a major modifiable risk factor, particularly in low- and middle-income countries where biomass fuel use and inadequate ventilation are widespread. For example, the World Health Organization (WHO) attributes over 4 million premature deaths annually to indoor air pollution, with respiratory diseases, including chronic cough, constituting a significant proportion. In developed nations, exposure to tobacco smoke, household cleaning agents, and building materials continues to pose substantial risks. The burden of chronic cough is further amplified by its impact on quality of life, healthcare utilization, and economic productivity.

Pathophysiology

The pathogenesis of chronic cough secondary to indoor pollutants involves multiple interrelated mechanisms. Inhalation of particulate matter (PM2.5, PM10), VOCs (e.g., formaldehyde, benzene), and biological allergens triggers airway inflammation, epithelial injury, and heightened cough reflex sensitivity. These agents can disrupt the mucociliary clearance system, promote oxidative stress, and induce neurogenic inflammation via activation of transient receptor potential (TRP) channels on sensory nerve endings. Chronic exposure leads to structural airway remodeling and persistent hypersensitivity of the cough reflex arc. Additionally, genetic predisposition and pre-existing respiratory conditions may modulate individual susceptibility to pollutant-induced cough.

Risk Factors

Risk stratification for chronic cough due to indoor pollutants requires consideration of both environmental and host-related factors. Key risk factors include: 1) type and concentration of indoor pollutants (e.g., tobacco smoke, cooking fumes, mold spores); 2) duration and frequency of exposure; 3) inadequate ventilation or use of biomass fuels; 4) occupational exposures (e.g., construction, cleaning); 5) underlying respiratory diseases such as asthma or chronic obstructive pulmonary disease (COPD); 6) genetic polymorphisms affecting airway sensitivity; and 7) sociodemographic variables, including age, socioeconomic status, and housing conditions. Children, elderly individuals, and those with compromised immune systems are particularly vulnerable.

Clinical Features

Patients with chronic cough attributable to indoor pollutants typically present with a dry, non-productive cough, though sputum production may occur in cases with concomitant airway inflammation or infection. The cough is often persistent, worse at night or upon waking, and may be accompanied by symptoms such as throat irritation, wheezing, dyspnea, or nasal congestion. Chronic exposure may also contribute to recurrent respiratory infections, asthma exacerbations, or the development of hypersensitivity pneumonitis. A thorough clinical history focusing on environmental exposures is critical for accurate assessment.

Diagnosis

Diagnostic evaluation begins with a detailed exposure history, including assessment of home and occupational environments, smoking status, and use of biomass fuels or chemicals. Physical examination may reveal non-specific findings such as pharyngeal erythema or wheezing. Objective assessment of indoor air quality, when feasible, provides valuable corroborative data. Pulmonary function tests, chest imaging, and exclusion of other common causes (e.g., asthma, gastroesophageal reflux, medication-induced cough) are essential components of the work-up. Biomarker studies (e.g., exhaled nitric oxide, induced sputum) and cough reflex sensitivity testing are emerging adjuncts in research settings. In select cases, referral to a respiratory specialist or environmental health expert may be warranted.

Treatment & Management

The cornerstone of management is identification and mitigation of indoor pollutant exposures. This may involve smoking cessation, improved home ventilation, use of air purifiers, and substitution of less toxic cleaning agents or building materials. Pharmacological interventions, such as inhaled corticosteroids or antitussives, are considered in patients with persistent symptoms or underlying airway inflammation. Patient education regarding environmental control measures and symptom monitoring is vital. In cases with severe or refractory cough, multidisciplinary approaches involving pulmonologists, allergists, and occupational health specialists are recommended.

Recent Advances / Emerging Therapies

Recent advances in the field include the development of smart air quality monitoring systems and wearable sensors for real-time exposure assessment. Novel pharmacotherapies targeting specific neurogenic pathways, such as P2X3 receptor antagonists, have shown promise in clinical trials for chronic refractory cough. Ongoing research is exploring the role of microbiome modulation and anti-inflammatory biologics in select patient populations. Furthermore, advances in building design and implementation of green technologies are being investigated for their potential to reduce indoor pollutant levels and associated respiratory morbidity.

Guideline Recommendations

International guidelines, including those from the American College of Chest Physicians (CHEST) and the European Respiratory Society (ERS), emphasize a systematic approach to chronic cough, with thorough evaluation of environmental and occupational exposures. Key recommendations include: 1) routine inquiry about indoor pollutant exposures in all patients with chronic cough; 2) prompt implementation of exposure mitigation strategies; 3) judicious use of pharmacotherapy based on underlying pathophysiology; and 4) ongoing monitoring of symptom response and environmental conditions. Guideline-directed care should be individualized and multidisciplinary when appropriate.

Conclusion

Chronic cough attributable to indoor pollutants represents a significant clinical and public health challenge, demanding heightened awareness among healthcare professionals. Comprehensive risk assessment, prompt identification of modifiable exposures, and implementation of evidence-based interventions are essential to improving patient outcomes. Continued research into the mechanisms, biomarkers, and emerging therapies for pollutant-induced cough will further refine diagnostic and management strategies. By integrating guideline recommendations and leveraging recent technological advances, clinicians can play a pivotal role in reducing the burden of chronic cough related to indoor air quality.